PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808943
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808943
Lab Automation in Protein Engineering Market size was valued at US$ 3,210.92 Million in 2024, expanding at a CAGR of 10.11% from 2025 to 2032.
Lab Automation in Protein Engineering pertains to the implementation of cutting-edge technologies, including robotics, liquid handling systems, software platforms, and integrated instrumentation, to automate numerous processes associated with protein design, development, and analysis. This approach is extensively utilized in fields such as directed evolution, protein expression and purification, and structure-function analysis, enabling researchers to swiftly evaluate thousands of protein variants. By reducing manual intervention and minimizing human error, lab automation not only lowers operational costs but also enhances the quality and reliability of results, thereby playing a vital role in expediting advancements in drug discovery, synthetic biology, and industrial biotechnology.
Lab Automation in Protein Engineering Market- Market Dynamics
Demand for Protein-Based Therapeutics is expected to drive the market growth
As pharmaceutical and biotechnology companies increasingly focus on the creation of monoclonal antibodies, enzymes, and various therapeutic proteins, there is an escalating need for efficient, high-throughput, and reproducible workflows in protein engineering. In 2019, the biotechnology sector generated USD 266 billion in drug revenues, a figure that has been steadily rising over the past few years. It is expected to reach USD 505 billion by 2026, while the conventional drug market is anticipated to be valued at USD 681 billion in the same year. Furthermore, the incorporation of AI and Machine Learning in workflow design offers substantial growth prospects for the market. Nevertheless, challenges related to data management and interoperability issues may impede market expansion.
Lab Automation in Protein Engineering Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.11% over the forecast period (2025-2032)
Based on product type segmentation, Robotic Liquid Handling Systems was predicted to show maximum market share in the year 2024
Based on Application segmentation, Drug Discovery was the leading Application in 2024
Based on end user segmentation, Academic and Research Institutes was the leading end user in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Lab Automation in Protein Engineering Market is segmented on the basis of Product Type, Workflow Stage, Application, Technology, End User, and Region.
The market is segmented into three categories according to product type: Robotic Liquid Handling Systems, Microplate Readers, Automated Workstations, High Throughput Screening Systems, and Mass Spectrometers. Robotic Liquid Handling Systems lead the market. These systems are predominant in the Lab Automation sector for Protein Engineering, owing to their exceptional precision, high throughput, and capability to simplify intricate workflows such as sample preparation, reagent dispensing, and assay development. They greatly improve efficiency and reproducibility in protein engineering processes, establishing themselves as an essential element in high-throughput screening and drug discovery initiatives.
The market is categorized into two segments according to Workflow Stage: Sample Preparation, Assay Development, Analysis and Detection, Data Acquisition, and Results Interpretation. During the Sample Preparation phase, robotic systems guarantee precision and uniformity in pipetting, reagent dispensing, and sample mixing. In the Assay Development stage, automation enhances the design and refinement of intricate experimental protocols, allowing for effective screening of protein variants. The Analysis and Detection phase benefits from integrated platforms that facilitate swift and consistent evaluation of protein activity, structure, and interactions. Finally, in the Data Acquisition and Results Interpretation stage, informatics and bioinformatics tools utilized by academic laboratories optimize large-scale data management and promote meaningful interpretation. The growing emphasis on reproducible science, the availability of funding, and the need for expedited discovery processes place academic and research institutions at the leading edge of adopting laboratory automation technologies.
The market is divided into five categories based on Application: Drug Discovery, Protein Expression, Protein Characterization, Disease Diagnosis and Biochemical Analysis. Among these, Drug Discovery leads the market, driven by the urgent need for high-throughput screening, rapid compound evaluation, and accelerated therapeutic development. Automation technologies in this domain enable the precise handling of small volumes, efficient assay setup, and integration with detection systems significantly improving productivity and reducing human error. In Protein Expression, automated systems streamline the expression and purification of recombinant proteins, enhancing scalability and reproducibility. Protein Characterization benefits from technologies such as automated electrophoresis, chromatography, and mass spectrometry, which allow for detailed analysis of protein structure and function. For Disease Diagnosis, automation supports rapid and accurate biomarker detection, while in Biochemical Analysis, it facilitates complex workflows such as enzyme kinetics and metabolic profiling. These technologies collectively enable faster, more reliable protein research and development across multiple sectors.
The market is categorized into four segments according to Technology: The incorporation of cutting-edge technologies such as Liquid Handling Technology, Robotics, Informatics Solutions, Bioinformatics Tools, and Imaging Technologies is transforming laboratory workflows and enhancing research capabilities. Liquid handling systems allow for accurate and automated fluid dispensing, greatly improving precision and throughput in experimental procedures. Robotics boosts automation by executing repetitive tasks with speed and reliability, thus minimizing human error and enhancing productivity. Informatics Solutions are essential for managing and analyzing extensive datasets, while Bioinformatics Tools aid in the interpretation of intricate biological data. Moreover, Imaging Technologies provide high-resolution visualization and real-time monitoring of biological processes, granting researchers deeper insights. Collectively, these technologies are optimizing research workflows, expediting discovery, and reshaping the environment of contemporary laboratories.
The market is segmented into five categories according to End-User: Pharmaceutical Companies, Biotechnology Firms, Academic and Research Institutes, Contract Research Organizations (CROs), and Government Laboratories. Academic and Research Institutes dominate the market. They lead the Lab Automation in Protein Engineering sector, propelled by substantial investments in cutting-edge research infrastructure and an increasing focus on high-throughput experimentation. These institutions are at the leading edge of creating innovative protein-based therapeutics, functional proteins, and biotechnological advancements. Automation technologies, including robotic liquid handling systems, bioinformatics tools, and imaging technologies, are extensively utilized in academic environments to enhance protein expression, characterization, and analysis processes. Consequently, Academic and Research Institutes are crucial in influencing technological progress and market expansion in protein engineering automation.
Lab Automation in Protein Engineering Market- Geographical Insights
North America leads in market growth, driven by increasing investments in biopharmaceutical research and development, along with the rising demand to minimize manual errors and enhance laboratory productivity. The region enjoys a strong presence of pharmaceutical and biotechnology firms, advanced research facilities, and favorable government funding. As reported by Digital Elevator, in 2021, the United States emerged as the leading player in the global biotech sector, representing nearly 59% of the total global biotech value. In contrast, China accounted for about 11%. Europe ranks as the second largest region for market growth, owing to robust biotech R&D and regulatory support for biologics and personalized medicine.
The Lab Automation in Protein Engineering Market is characterized by intense competition and a strong emphasis on technology, with leading companies vying for supremacy through innovation, diverse product offerings, automation capabilities, and the incorporation of AI/ML to improve protein design and analysis. Manufacturers compete based on factors such as the flexibility of automation, throughput capabilities, integration with AI and bioinformatics tools, and tailored workflow solutions. Furthermore, the heightened emphasis on high-throughput screening, directed evolution, and structural protein studies has led firms to allocate resources towards R&D and forge strategic partnerships with research institutions. As the need for precision and reproducibility escalates in synthetic biology and biopharmaceutical research, competition is becoming increasingly fierce, particularly in emerging markets such as Asia-Pacific.
Thermo Fisher Scientific Inc., recognized as the global leader in scientific services, has today unveiled the Thermo Scientific Vulcan Automated Lab, an innovative solution aimed at ushering in a new era of process development and control within the semiconductor manufacturing sector.
Husqvarna Group, a worldwide leader in outdoor power equipment and robotics, has unveiled four new robust robotic lawnmowers designed for commercial applications. These state-of-the-art models broaden the wire-free options available, improving flexibility and further transforming turf management for sports fields, golf courses, and facility upkeep.